Hyundai Engineering Co. will build a 400 billion won plant in Dangjin that uses plastic wastes in producing high-purity clean hydrogen.
The plant will process 100,000 tons of plastic wastes annually to produce 22,000 tons of high-purity clean hydrogen through pyrolysis and gasification.
The hydrogen produced will be used as a raw material for hydrogen-electric vehicles, hydrogen-LNG co-firing power generation, hydrogen fuel cell power generation.
The plant is part of efforts to diversify its business towards eco-friendly energy production.
The company, a plant engineering affiliate of Hyundai Motor Group, expects to break ground in the first half of next year.
Full-scale commercial production is expected to begin in 2024.
Hyundai Engineering will collect and use most of the carbon dioxide generated during the process through a Metal-CO2 system that is now being tested at Hyundai Steel Co.’s Incheon plant.


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
The UK is surprisingly short of water – but more reservoirs aren’t the answer
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
Asian Currencies Trade Sideways as Dollar Stabilizes, Yen Weakens Ahead of Japan Election
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 



